captopril has been researched along with Infections, Klebsiella in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergstrom, A; Bethel, CR; Bonomo, RA; Chen, AY; Cheng, Z; Cohen, SM; Credille, CV; Crowder, MW; Fast, W; Marshall, SH; Miller, C; Page, RC; Riley, CL; Stewart, AC; Thomas, PW; Tierney, DL | 1 |
| Dai, Y; Gao, Y; Li, H; Li, J; Liu, Y; Sun, K; Yue, C; Zhang, H; Zhao, D | 1 |
2 other study(ies) available for captopril and Infections, Klebsiella
| Article | Year |
|---|---|
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Picolinic Acids; Structure-Activity Relationship | 2017 |
Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.
Topics: Anti-Bacterial Agents; Antihypertensive Agents; beta-Lactamases; Captopril; Carbapenem-Resistant Enterobacteriaceae; Drug Therapy, Combination; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2021 |